Evidence map›Paper›PMID 39890789›Full record

ArticleNature communications2025

Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma.

Yuchuan Zhou, Liang Zeng, Linbo Cai, Wang Zheng, Xinglong Liu, Yuqi Xiao, Xiaoya Jin, Yang Bai, Mingyao Lai, Hainan Li and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. [Molecular Mechanism of microRNA-429 TargetingSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.Signal transduction and targeted therapy · 2026
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuchuan Zhou *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Liang Zeng *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Linbo Cai *Department of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Wang ZhengInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Xinglong LiuInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Yuqi XiaoInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Xiaoya JinInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Yang BaiInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
Mingyao LaiDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Hainan LiDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Hua JiangSchool of Biomedical Engineering, Shanghai Tech University, Shanghai, China.
Songling HuDepartment of Preventive Dentistry, Shanghai Stomatological Hospital & School of Stomatology, Shanghai Medical College, Fudan University, Shanghai, China.
Yan PanInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China. swallowpan@fudan.edu.cn.ORCID http://orcid.org/0000-0003-4307-3616
Jianghong ZhangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China. zjh551268@fudan.edu.cn.ORCID http://orcid.org/0000-0003-4884-6411
Chunlin ShaoInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, China. clshao@shmu.edu.cn.ORCID http://orcid.org/0000-0001-9336-9912

Funding

National Natural Science Foundation of China (National Science Foundation of China) 12175044National Natural Science Foundation of China (National Science Foundation of China) 12375338
6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) remains a therapeutic challenge due to its aggressive nature and recurrence. This study establishes a radioresistant GBM cell model through repeated irradiation and observes a cellular senescence-like phenotype in these cells. Comprehensive genomic and transcriptomic analyses identify IFI16 as a central regulator of this phenotype and contributes to radioresistance. IFI16 activates HMOX1 transcription thereby attenuating ferroptosis by reducing lipid peroxidation, ROS production, and intracellular Fe

Indexed as

Brain NeoplasmsCellular SenescenceFerroptosisGlioblastomaHeme Oxygenase-1Nuclear ProteinsPhosphoproteinsRadiation ToleranceAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansLipid PeroxidationMiceReactive Oxygen SpeciesHeme Oxygenase-1HMOX1 protein, humanIFI16 protein, humanNuclear ProteinsPhosphoproteinsReactive Oxygen Species

Identifiers

PMID39890789
PMCPMC11785807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.